Explore the Agenda

8:00 am Morning Coffee & Workshop Check-In

Workshop A

9:00 am Transforming Covalent Warhead Design by Aligning Chemistry with Developability & Translational Expectations to Accelerate Progression Towards IND

Vice President, Biochemistry & Chemical Biology, Flare Therapeutics

As covalent programs mature, early warhead design decisions increasingly determine whether compounds progress or stall during translation. This workshop will examine how chemistry choices interact with PK/PD behavior, developability constraints and translational expectations, helping teams design warheads that remain viable through optimization and into IND enabling studies.

This session will address:

• Exploring non-acrylamide chemotypes and beyond to evaluate how alternative warhead chemistries electrophiles, alongside electrophile choice, placement, and scaffold context drive covalent engagement and selectivity

• Leveraging chemoproteomics and cellular covalent screening to profile target engagement and proteome-wide reactivity, enabling data-driven optimization and prioritization of warhead strategies

• Learning from real-world case studies, including deprioritized programs to uncover key pitfalls, unexpected liabilities, and transferable insights that improve decision making and reduce late-stage risk

12:00 pm Lunch Break & Networking

Workshop B

1:00 pm Optimizing Translational Readiness in Covalent Programs Through Robust Integration of kinact/KI & Selectivity Data

Senior Director, Antares Therapeutics

Covalent development generates complex kinetic and selectivity data that are often difficult to reconcile across assays and systems. This workshop will focus on how kinact/KI, target engagement and selectivity readouts can be integrated to build translational readiness, supporting clearer alignment between discovery data, PK/PD strategy and downstream development planning.

This session will address:

• Assessing how kinetic, selectivity and target engagement data can be integrated across biochemical and cellular systems to build a consistent view of covalent behavior

• Comparing approaches to generating and contextualizing kinact/KI measurements, including their applicability and limitations across enzyme and non‑enzyme targets

• Linking kinetic and selectivity profiles with early safety and PK/PD considerations to support translational planning and downstream development strategy

4:00 pm End of Pre-Conference Workshop Day